Cargando…
The MYEOV-MYC association promotes oncogenic miR-17/93-5p expression in pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy worldwide. As metastasis and malignant progression are primarily responsible for the poor clinical outcomes of PDAC, identifying key genes involved in these processes and the underlying molecular mechanisms of PDAC is vital. In th...
Autores principales: | Shen, Hongzhang, Ye, Fuqiang, Xu, Dongchao, Fang, Liangliang, Zhang, Xiaofeng, Zhu, Juanjuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688437/ https://www.ncbi.nlm.nih.gov/pubmed/34930894 http://dx.doi.org/10.1038/s41419-021-04387-z |
Ejemplares similares
-
RUNX1 promote invasiveness in pancreatic ductal adenocarcinoma through regulating miR-93
por: Cheng, Yin, et al.
Publicado: (2017) -
Identification of MYEOV-Associated Gene Network as a Potential Therapeutic Target in Pancreatic Cancer
por: Chen, Yu, et al.
Publicado: (2022) -
Role of miR-30a-3p Regulation of Oncogenic Targets in Pancreatic Ductal Adenocarcinoma Pathogenesis
por: Shimomura, Hiroki, et al.
Publicado: (2020) -
MYEOV overexpression induced by demethylation of its promoter contributes to pancreatic cancer progression via activation of the folate cycle/c-Myc/mTORC1 pathway
por: Tange, Shoichiro, et al.
Publicado: (2023) -
Net1 and Myeov: computationally identified mediators of gastric cancer
por: Leyden, J, et al.
Publicado: (2006)